Case Reports in Gastroenterology最新文献

筛选
英文 中文
Post-Pancreatitis Splenic Artery Pseudoaneurysm as a Luring Danger: A Case Report. 胰腺炎后脾动脉假性动脉瘤的危险:1例报告。
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-17 eCollection Date: 2025-01-01 DOI: 10.1159/000546314
Daniel Schweckendiek, Kuno Lehmann, Vincent Van den Bosch
{"title":"Post-Pancreatitis Splenic Artery Pseudoaneurysm as a Luring Danger: A Case Report.","authors":"Daniel Schweckendiek, Kuno Lehmann, Vincent Van den Bosch","doi":"10.1159/000546314","DOIUrl":"10.1159/000546314","url":null,"abstract":"<p><strong>Introduction: </strong>Splenic artery aneurysm (SAA) is a rare but potentially life-threatening condition. SAA can occur following an acute or chronic pancreatitis as a pseudoaneurysm, iatrogenic (post-pancreatic/splenic surgery) or post-traumatic. If symptomatic, it needs to be treated urgently as it has a high risk of rupture.</p><p><strong>Case presentation: </strong>Here is a case where a ruptured aneurysm presented in an unusual manner: first as an acute abdomen and second, delayed, as hemorrhagic shock. Only emergency laparotomy and splenectomy saved the patient's life.</p><p><strong>Conclusion: </strong>If a splenic artery pseudoaneurysm is detected on CT scan, there is an increased risk of rupture irrespective of the size and the patient that should be proactively managed. Concomitant abdominal findings and diseases can delay diagnosis and underestimate the risk.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"439-444"},"PeriodicalIF":0.5,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12173440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ribavirin Treatment in Acute HEV-Induced Liver Injury in a Healthy US Female: A Case Report. 利巴韦林治疗美国健康女性急性hev诱导肝损伤1例
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-17 eCollection Date: 2025-01-01 DOI: 10.1159/000546235
Nadera Altork, Michele P Fischer, Lukman Cheraghvandi, Arul M Thomas
{"title":"Ribavirin Treatment in Acute HEV-Induced Liver Injury in a Healthy US Female: A Case Report.","authors":"Nadera Altork, Michele P Fischer, Lukman Cheraghvandi, Arul M Thomas","doi":"10.1159/000546235","DOIUrl":"10.1159/000546235","url":null,"abstract":"<p><strong>Introduction: </strong>Hepatitis E virus (HEV) is a global cause of acute viral hepatitis, for which there is currently no FDA-approved medication. This case report describes a unique instance of a healthy US female presenting with acute HEV, who was treated with ribavirin to address her acute liver injury.</p><p><strong>Case presentation: </strong>A 36-year-old US female, nonpregnant, without liver disease, developed nonspecific symptoms post-travel to Indonesia, leading to acute liver injury with concern for failure. Liver biopsy showed severe hepatocellular necrosis (>50%) with mixed infiltrate; HEV PCR was positive (93,700,000 IU/mL) [Am J Gastroenterol. 2024;119(10S):S2872-3]. After risk-benefit analysis, ribavirin treatment resolved symptoms and normalized biomarkers in a month, avoiding emergency transplantation.</p><p><strong>Conclusion: </strong>HEV infection should be considered in acute liver injury cases in the US, especially with exposure risks. Ribavirin's role in acute cases warrants further study, potentially averting major morbidity and mortality.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"455-460"},"PeriodicalIF":0.5,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12173439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opioid Withdrawal Misdiagnosed as a Crohn's Flare. 阿片类药物戒断被误诊为克罗恩病。
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-13 eCollection Date: 2025-01-01 DOI: 10.1159/000546335
Matthew Christopher Ryan, Marcel Jose Yibirin Wakim, Sebastian Suarez
{"title":"Opioid Withdrawal Misdiagnosed as a Crohn's Flare.","authors":"Matthew Christopher Ryan, Marcel Jose Yibirin Wakim, Sebastian Suarez","doi":"10.1159/000546335","DOIUrl":"10.1159/000546335","url":null,"abstract":"<p><strong>Introduction: </strong>There is an increased incidence of opioid use disorder (OUD) originating from prescription misuse. Diagnosing OUD remains challenging, particularly in patients with multiple medical comorbidities where other potential etiologies may cause overlapping symptoms.</p><p><strong>Case presentation: </strong>This report highlights a 28-year-old male with Crohn's disease (CD) with recurrent hospitalizations of abdominal pain, hematuria, nausea, vomiting, and diarrhea. An extensive workup was negative for a Crohn's flare; however, the patient's symptoms improved within 48 h of admission, coinciding with opioid administration for pain management. Subsequently, the patient was diagnosed with opioid withdrawal and discharged with a buprenorphine clinic appointment to initiate medications for OUD.</p><p><strong>Conclusion: </strong>This case highlights the complexity of diagnosing opioid withdrawal in a patient with CD and the persistent stigma in the healthcare community regarding persons who use opioids.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"434-438"},"PeriodicalIF":0.5,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144301178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curcumin-QingDai Combination as Treatment for Crohn's Disease: A Case Report. 姜黄-清脉联合治疗克罗恩病1例
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-11 eCollection Date: 2025-01-01 DOI: 10.1159/000546012
Netanel Krugliak, Mark S Silverberg
{"title":"Curcumin-QingDai Combination as Treatment for Crohn's Disease: A Case Report.","authors":"Netanel Krugliak, Mark S Silverberg","doi":"10.1159/000546012","DOIUrl":"10.1159/000546012","url":null,"abstract":"<p><strong>Introduction: </strong>Curcumin and QingDai (QD, indigo) are two herbal extracts used in traditional medicine. A combination of curcumin with QD (CurQD) was reported to be effective in ulcerative colitis, but its effectiveness in Crohn's disease (CD) is unknown. We report on the use of CurQD for the treatment of CD.</p><p><strong>Case presentation: </strong>The patient was a 35-year-old male with colonic and perianal CD responsive to infliximab therapy, who had to discontinue therapy due to a concomitant cardiomyopathy diagnosis. After cessation of infliximab treatment, he experienced clinical and endoscopic relapse which responded to initiation of CurQD therapy with regained clinical and endoscopic remission.</p><p><strong>Conclusion: </strong>In summary, the present case report describes, for the first time, a possible benefit of CurQD nutraceutical in the induction and maintenance of remission in a Crohn's patient. However, more data, preferably from adequately powered randomized controlled trials, are needed to corroborate these observations.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"423-427"},"PeriodicalIF":0.5,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144274261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diarrhea, Weight Loss, and an Elevated Gastrin: A Case Report. 腹泻、体重减轻和胃泌素升高:1例报告。
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-11 eCollection Date: 2025-01-01 DOI: 10.1159/000545714
Ryan G Alexander, John C Cheville, Geoffrey B Thompson, Glenn L Alexander
{"title":"Diarrhea, Weight Loss, and an Elevated Gastrin: A Case Report.","authors":"Ryan G Alexander, John C Cheville, Geoffrey B Thompson, Glenn L Alexander","doi":"10.1159/000545714","DOIUrl":"10.1159/000545714","url":null,"abstract":"<p><strong>Introduction: </strong>Hypergastrinemia in a patient with refractory reflux, steatorrhea, or peptic ulcer disease with a gastric pH <4 is concerning for Zollinger-Ellison syndrome (ZES), but antral G-cell hyperplasia can also present in this manner and is distinguished from ZES based on negative radiographic studies and secretory stimulation testing with a typical gastrin response to a standardized test meal.</p><p><strong>Case presentation: </strong>A 51-year-old female with a history of a Nissen fundoplication for refractory reflux presented with a 3-month history of heartburn, diarrhea, and 55-pound weight loss. Evaluation included negative upper and lower endoscopies with biopsies and negative MR enterography. A 48-h fecal fat study revealed 501 g of stool and 51 g of fat per 24 h. A serum gastrin level off PPI was elevated at 589 pg/mL with a gastric pH of 2 on gastric aspirate. An EUS, DOTATATE PET scan, and secretin stimulation test were negative for ZE. A standardized test meal with serial gastrin monitoring demonstrated an 8-fold increase in serum gastrin. Open abdominal exploration and intraoperative ultrasound showed no evidence of a gastrinoma and an antrectomy and Billroth II anastomosis was performed in treatment of G-cell hyperplasia. Pathology demonstrated a moderately increased G-cell population. Postoperatively, her hypergastrinemia and steatorrhea resolved and she regained 60 pounds.</p><p><strong>Conclusion: </strong>Antral G-cell hyperplasia should be considered in patients with symptoms suggestive of gastrinoma with negative secretin stimulation testing and imaging studies. A standardized test meal demonstrates a substantial increase in serum gastrin levels and antrectomy is the treatment of choice for refractory symptoms.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"428-433"},"PeriodicalIF":0.5,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144274262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calculus Cholecystitis Complicated with Variations of Extrahepatic Bile Duct: Clinical Experience and Aeromedical Analysis of 3 Cases in Aviation Pilots. 航空飞行员结石性胆囊炎合并肝外胆管病变3例临床体会及航空医学分析。
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-09 eCollection Date: 2025-01-01 DOI: 10.1159/000546233
Wen-Bing Li, Zeng Xue, Wei Shi, Lu-Bing Wang, Xiao-Jun He, Cheng Wang, Gang Zhao, Ling-Hong Kong, Meng Pu, Cheng-Li Liu, Ya-Lin Kong
{"title":"Calculus Cholecystitis Complicated with Variations of Extrahepatic Bile Duct: Clinical Experience and Aeromedical Analysis of 3 Cases in Aviation Pilots.","authors":"Wen-Bing Li, Zeng Xue, Wei Shi, Lu-Bing Wang, Xiao-Jun He, Cheng Wang, Gang Zhao, Ling-Hong Kong, Meng Pu, Cheng-Li Liu, Ya-Lin Kong","doi":"10.1159/000546233","DOIUrl":"10.1159/000546233","url":null,"abstract":"<p><strong>Introduction: </strong>For aviation personnel, calculous cholecystitis often requires surgical treatment because of the potential risks to flight safety whether symptomatic or asymptomatic. Although much effort has been put on the precaution of gallstone formation, the incidence of long-term post-cholecystectomy syndrome (PCS) seems more apparent in the limited number of cases undergoing cholecystectomy. The purpose of article was to elucidate the possible mechanism of gallstone formation and the development of long-term PCS caused by variations of bile duct, as well as choice of surgical treatments, just in this particular group of aviation personnel.</p><p><strong>Case presentation: </strong>Seven aviation pilots who underwent laparoscopic cholecystectomy in recent 5 years were reviewed, and 3 cases who developed long-term PCS because of variations of bile duct were presented. Variations of bile duct included existence of accessory extrahepatic bile, absence of common bile duct, and absence of cystic duct. Long-term PCS was characterized as epigastric dull pain and diarrhea or sparse stool, and became aggravated when resuming trainings of flight stimulations. Dietary adjustment and oral antispasmodic or cholagogic drug therapy, combined with relieving apprehensions after surgery, helped them recover well and resume flight.</p><p><strong>Conclusion: </strong>Variation of bile duct may be an important potential risk for gallstone formation and development of long-term PCS with the cause of probable decrement of bile drainage under the physiological environment of aviation.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"412-422"},"PeriodicalIF":0.5,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12148319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144257426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First Description of Sprue-Like Enteropathy due to Azilsartan: A Case Report. 阿兹沙坦引起的云杉样肠病1例报告。
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-06 eCollection Date: 2025-01-01 DOI: 10.1159/000545217
Luisa Stoeckli, Markus Koster, Tugce Tuerkmen-Uthayanan, Sergio Cogliatti, Stephan Brand
{"title":"First Description of Sprue-Like Enteropathy due to Azilsartan: A Case Report.","authors":"Luisa Stoeckli, Markus Koster, Tugce Tuerkmen-Uthayanan, Sergio Cogliatti, Stephan Brand","doi":"10.1159/000545217","DOIUrl":"10.1159/000545217","url":null,"abstract":"<p><strong>Introduction: </strong>Sartan-induced enteropathy is an uncommon side effect of treatment with angiotensin II receptor antagonists (ARBs), which has predominantly been described for olmesartan.</p><p><strong>Case presentation: </strong>For the first time, we describe sartan-induced enteropathy as an adverse drug reaction associated with azilsartan in a 74-year-old male patient who was admitted to the hospital twice within 5 months because of excessive non-bloody diarrhea and weight loss. In this case, histopathological findings of intraepithelial lymphocytosis and intestinal villous atrophy resembled celiac disease; however, celiac disease-specific antibodies remained negative, and a gluten-free diet did not result in significant clinical recovery, while symptoms stopped rapidly after stopping azilsartan. When the patient was seen 5 months later, he was free of clinical symptoms, and histological changes disappeared after stopping azilsartan.</p><p><strong>Conclusion: </strong>This case illustrates sprue-like enteropathy as a potential side effect of azilsartan, emphasizing to consider this differential diagnosis in ARB-treated patients with chronic diarrhea. The causality of our findings was confirmed by drug de-challenge and re-challenge resulting in typical histological changes.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"403-411"},"PeriodicalIF":0.5,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12143864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144246583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Recurrent Gallstone Ileus Treated with Enterolithotomy Alone. 单纯肠内取石术治疗复发性胆结石性肠梗阻1例。
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-05 eCollection Date: 2025-01-01 DOI: 10.1159/000545980
Kisho Noda, Hirofumi Ohno, Keiko Naito, Katsudai Shirakabe, Hirotada Muramatsu, Hiraku Funakoshi
{"title":"A Case of Recurrent Gallstone Ileus Treated with Enterolithotomy Alone.","authors":"Kisho Noda, Hirofumi Ohno, Keiko Naito, Katsudai Shirakabe, Hirotada Muramatsu, Hiraku Funakoshi","doi":"10.1159/000545980","DOIUrl":"10.1159/000545980","url":null,"abstract":"<p><strong>Introduction: </strong>Gallstone ileus is rare but with high mortality. Although gallstone ileus usually requires urgent enterolithotomy, cholecystectomy, and fistula closure, we present a case of recurrent gallstone ileus treated with enterolithotomy alone.</p><p><strong>Case presentation: </strong>A 69-year-old female presented to the emergency department with nausea, emesis, and abdominal pain. After computed tomography revealed the diagnosis of gallstone ileus, enterolithotomy was performed without postoperative complications. Cholecystectomy and fistula closure were not performed due to inaccessibility to the gallbladder and the high surgical invasion required. Four months later, the patient developed gallstone ileus again. A second enterolithotomy was performed immediately, resulting in a favorable outcome without complications.</p><p><strong>Conclusion: </strong>In managing gallstone ileus, particularly in cases with surgical limitations, a less invasive strategy could be a reasonable option.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"397-402"},"PeriodicalIF":0.5,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144233273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infliximab-Induced Immune Thrombocytopenic Purpura in an Ulcerative Colitis Patient. 溃疡性结肠炎患者英夫利昔单抗诱导的免疫性血小板减少性紫癜。
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-06-04 eCollection Date: 2025-01-01 DOI: 10.1159/000545922
Mark Lai, Timothy Phan, Ola Niewiadomski, Nik Ding
{"title":"Infliximab-Induced Immune Thrombocytopenic Purpura in an Ulcerative Colitis Patient.","authors":"Mark Lai, Timothy Phan, Ola Niewiadomski, Nik Ding","doi":"10.1159/000545922","DOIUrl":"10.1159/000545922","url":null,"abstract":"<p><strong>Introduction: </strong>Ulcerative colitis is a chronic inflammatory disease affecting the colon. Anti-tumor necrosis factor-alpha drugs are a cornerstone of management in ulcerative colitis both in induction and maintenance of remission. Thrombocytopenia is a rare side effect of these drugs.</p><p><strong>Case presentation: </strong>We present a case of infliximab-induced immune thrombocytopenic purpura in a 34-year-old female ulcerative colitis patient.</p><p><strong>Conclusion: </strong>Infliximab can be a cause of drug-induced immune-related thrombocytopenia and patient's platelet counts should be regularly monitored. In patients with severe thrombocytopenia and having been recently commenced on infliximab, prompt referral to hematology specialty is essential.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"392-396"},"PeriodicalIF":0.5,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136565/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144224403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Closure of Chronic Colonic Double Perforation Caused by a Plastic Biliary Stent with Over-the-Scope Clip. 塑料胆道支架镜外夹成功闭合慢性结肠双穿孔。
IF 0.5
Case Reports in Gastroenterology Pub Date : 2025-05-29 eCollection Date: 2025-01-01 DOI: 10.1159/000545561
Manuel Lehner, Henriette Heinrich, Benjamin Baumgartner, Tobias Heye, Marius Zimmerli
{"title":"Successful Closure of Chronic Colonic Double Perforation Caused by a Plastic Biliary Stent with Over-the-Scope Clip.","authors":"Manuel Lehner, Henriette Heinrich, Benjamin Baumgartner, Tobias Heye, Marius Zimmerli","doi":"10.1159/000545561","DOIUrl":"10.1159/000545561","url":null,"abstract":"<p><strong>Introduction: </strong>Biliary stenting is commonly used for managing bile duct conditions, with stent migration occurring in up to 21% of cases. Colonic perforation from stent migration is rare, typically managed surgically or with conventional endoscopic clips. The use of over-the-scope clips (OTSCs) for such perforations is less documented.</p><p><strong>Case presentation: </strong>An 89-year-old multimorbid woman presented with abdominal pain and new-onset constipation. Imaging revealed a migrated biliary stent causing sigmoid colon perforation. One year earlier, the stent had been placed for choledocholithiasis. Endoscopic removal of the stent and OTSC closure of the perforations were successfully performed, with no complications on follow-up.</p><p><strong>Conclusion: </strong>This case demonstrates the successful use of OTSCs for closing a chronic colonic perforation caused by a migrated biliary stent. OTSCs may be a viable, less invasive alternative to surgery in similar cases.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"381-386"},"PeriodicalIF":0.5,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121979/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144183594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信